GANNET53 — A drug strategy targeting stabilised mutant p53 to fight metastatic platinum-resistant ovarian cancer
European project no. 602602 — 18 consortium partners from Austria, Belgium, France and Germany
GANNET53 (Ganetespib in metastatic, p53 mutant, platinum-resistant ovarian cancer) is a FP7 research project funded by the European Commission. The project started in October 2013 and aims at improving prognosis and quality of life in platinum-resistant, p53 mutant ovarian cancer patients. The project is planned for 5.5 years with a funding of 6 million Euros.
OncoLab Diagnostics is leader of workpackage 6 “Companion Diagnostics” and has taken over the administrative project management.
Strips Diagnostics — Development of test kits for disease diagnosis based on test strip technology
Grant received from the ERP fund /AWS — Austria Wirtschaftsservice for the Strips Diagnostics project no. P0803239-PTK01
Project duration: 2012
OncoTest — Innovative blood test for earlier cancer detection
Grant provided by the Austrian Research Promotion Agency (FFG) for the OncoTest project no. 835445
Project duration: 2012 to 2013
OncoLab Diagnostics GmbH